We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma (VIT-0910)

This study is currently recruiting participants.
Verified July 2017 by Centre Oscar Lambret
Sponsor:
ClinicalTrials.gov Identifier:
NCT01355445
First Posted: May 18, 2011
Last Update Posted: July 21, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
SFCE
Information provided by (Responsible Party):
Centre Oscar Lambret
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2021
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)

To Top